黄斑变性
医学
德鲁森
眼科
地理萎缩
萎缩
视网膜色素上皮
视网膜
糖尿病性视网膜病变
内科学
糖尿病
内分泌学
作者
Katherine M. Overbey,Francesco Romano,Xinyi Ding,Cade Bennett,Isabella Stettler,Itika Garg,Ioanna Ploumi,Filippos Vingopoulos,Melissa Yuan,Peyman Razavi,Matthew J. Finn,Inês Laíns,Nimesh Patel,Leo A. Kim,David T. Wu,Dean Eliott,Deeba Husain,Demetrios G. Vavvas,Joan W. Miller,John B. Miller
标识
DOI:10.1136/bjo-2024-326416
摘要
Aims To assess choriocapillaris flow deficit percentage (CCFD%) across stages of dry age-related macular degeneration (AMD) using swept-source optical coherence tomography angiography (SS-OCTA). Methods This cross-sectional, observational study included 270 eyes (182 patients), classified as early (70 eyes), intermediate (121 eyes) and geographic atrophy (GA, 79 eyes). Participants underwent a complete examination including macular 6×6 mm SS-OCTA scans (PLEX Elite 9000). Scans were reviewed and analysed for subretinal drusenoid deposits (SDDs), retinal pigment epithelium (RPE) atrophy size, incomplete RPE and outer retinal atrophy (iRORA) and drusen volume (3 mm). CCFD% was calculated after compensation and binarisation using Phansalkar’s method (r=4–15 pixels) in various early treatment for diabetic retinopathy study sectors. Linear mixed-effects models adjusted for age evaluated associations with AMD stages and other imaging biomarkers. Results CCFD% progressively increased with advancing dry AMD stages. Intermediate AMD eyes showed higher CCFD% than early AMD ones across all regions (p<0.001). GA eyes exhibited significantly higher CCFD% compared with early (p<0.001) and intermediate AMD eyes (p<0.001). SDDs were significantly associated with higher CCFD% in early (p<0.01) and intermediate AMD (p<0.05) for almost all regions examined, but not in GA (p>0.05). iRORA presence in iAMD and larger RPE atrophy in GA correlated with increased CCFD% (p<0.001). Conclusions This study provides a comprehensive reference database for CCFD% across the stages of dry AMD using SS-OCTA. CCFD% increased with AMD severity, iRORA, SDDs, particularly in early and intermediate stages, and RPE atrophy size. Our findings support CCFD% as a valuable biomarker for clinical and research applications, warranting longitudinal studies to validate its prognostic value.
科研通智能强力驱动
Strongly Powered by AbleSci AI